Identify Bcl3 as a novel biomarker shared between severe asthma and lung cancer using next-generation RNA sequencing from archival FFPE tissue biopsies
L. Salameh (Dubai, United Arab Emirates), P. Manasa Bhamidimarri (Sharjah, United Arab Emirates), N. Elemam (Sharjah, United Arab Emirates), N. Ali (Sharjah, United Arab Emirates), Y. Dairi (Dubai, United Arab Emirates), M. Alsharhan (Dubai, United Arab Emirates), S. Tirmazy (Dubai, United Arab Emirates), Q. Hamid (Sharjah, United Arab Emirates), B. Mahboub (Dubai, United Arab Emirates), S. Al Heialy (Dubai, United Arab Emirates), R. Hamoudi (Sharjah, United Arab Emirates)
Source: International Congress 2022 – Identifying therapeutic targets and novel drug strategies in pulmonary diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Salameh (Dubai, United Arab Emirates), P. Manasa Bhamidimarri (Sharjah, United Arab Emirates), N. Elemam (Sharjah, United Arab Emirates), N. Ali (Sharjah, United Arab Emirates), Y. Dairi (Dubai, United Arab Emirates), M. Alsharhan (Dubai, United Arab Emirates), S. Tirmazy (Dubai, United Arab Emirates), Q. Hamid (Sharjah, United Arab Emirates), B. Mahboub (Dubai, United Arab Emirates), S. Al Heialy (Dubai, United Arab Emirates), R. Hamoudi (Sharjah, United Arab Emirates). Identify Bcl3 as a novel biomarker shared between severe asthma and lung cancer using next-generation RNA sequencing from archival FFPE tissue biopsies. 2827
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|